BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  BioCapital

  J&J and AstraZeneca’s Vaccine Woes Push Novavax Cautiously Into the Light

  Novavax is plugging along to get their COVID-19 vaccine candidate, NVX-CoV2373, through late-stage clinical trials and authorized in the U.S. and elsewhere.

  April 22, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Biogen’s Alzheimer’s Drug is in the Home Stretch, but Can it Win Approval?

  The long and strange journey of Biogen’s Alzheimer’s drug aducanumab is coming to an end. Whether it will be a complete ending—with the U.S. FDA rejecting it—or a new chapter, with an approval, remains to be seen.

  April 22, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Research Roundup: Immune Cell Differences in Asymptomatic Versus Severe COVID-19 and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  April 22, 2021

   · 

  6 min read

   · 

  Mark Terry
• 

  BioCapital

  Seed Health and Anavo Therapeutics Launch With Millions in in Early Financings

  New Series A financing rounds have been announced in the last two days, with Seed Health leading the pack followed by Anavo Therapeutics.

  April 22, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Career Advice

  Why Having Adaptive Leadership Skills Is a Perk for Your Life Sciences Career

  Why are adaptive leaders so useful? And is adaptive leadership a quality that will benefit your life sciences career? Let’s explore this concept and find out.

  April 22, 2021

   · 

  3 min read

   · 

  Kymberlie Krieger
• 

  Genetown

  Moderna Execs Sell Off Some Stock Shares to Capitalize on Gains, While Index Declines

  Shareholders have been pleased with the company’s mRNA vaccine, but some, including the company’s cofounder, are cashing in on their stock gains.

  April 22, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Newly-Launched Centessa Pharmaceuticals Already Planning $100 Million IPO

  Two months after Centessa Pharmaceuticals launched following the merger of 10 private biotech companies, the company is already eying a $100 million splash on the Nasdaq stock exchange.

  April 22, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Pharm Country

  Aptorum Enters Agreement With Yale to Develop, Investigate Novel Immunomodulators

  Clinical-stage biopharmaceutical company, Aptorum Group Limited, announced today that it has entered into a material transfer and option agreement with Yale University to study preclinical stage novel immunomodulators targeting autoimmune and oncology diseases.

  April 22, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Drug Development

  Ortho Dermatologics Announces More Positive Data for New Acne Vulgaris Therapy

  On the back of the two positive Phase III trials, Ortho said it will submit a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2022.

  April 22, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  Career Advice

  Tips for Demonstrating Best Skills On Your Leadership Skills Resume

  Regardless of the field that you work in, mentioning top skills in your resume is a crucial step. Here are some tips to prepare the best leadership skills resume.

  April 22, 2021

   · 

  4 min read

   · 

  Hannah Harshman